SOLENO THERAPEUTICS INC Quarterly Assets in USD from Q4 2013 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Soleno Therapeutics Inc quarterly Assets history and growth rate from Q4 2013 to Q4 2024.
Soleno Therapeutics Inc Assets for the quarter ending December 31, 2024 was $331M, a 83.2% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$331M	+$150M	+83.2%	Dec 31, 2024	10-K	2025-02-28
Q3 2024	$297M	+$233M	+367%	Sep 30, 2024	10-Q	2024-11-06
Q2 2024	$304M	+$273M	+883%	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$169M	+$149M	+764%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$181M	+$154M	+582%	Dec 31, 2023	10-K	2025-02-28
Q3 2023	$63.5M	+$31.6M	+98.7%	Sep 30, 2023	10-Q	2023-11-08
Q2 2023	$30.9M	-$5.92M	-16.1%	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$19.5M	-$23M	-54.1%	Mar 31, 2023	10-Q	2023-05-09
Q4 2022	$26.5M	-$9.06M	-25.5%	Dec 31, 2022	10-K	2024-03-07
Q3 2022	$32M	-$10.6M	-24.9%	Sep 30, 2022	10-Q	2022-11-09
Q2 2022	$36.9M	-$11.9M	-24.4%	Jun 30, 2022	10-Q	2022-08-10
Q1 2022	$42.5M	-$14.2M	-25%	Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$35.6M	-$29.4M	-45.3%	Dec 31, 2021	10-K	2023-03-22
Q3 2021	$42.6M	-$29.2M	-40.7%	Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$48.8M	-$30.1M	-38.1%	Jun 30, 2021	10-Q	2021-07-28
Q1 2021	$56.7M	+$24.6M	+76.6%	Mar 31, 2021	10-Q	2021-05-05
Q4 2020	$65M	+$26.8M	+70.2%	Dec 31, 2020	10-K	2022-03-31
Q3 2020	$71.8M	+$43.1M	+150%	Sep 30, 2020	10-Q	2020-11-10
Q2 2020	$78.9M	+$44.7M	+131%	Jun 30, 2020	10-Q	2020-08-10
Q1 2020	$32.1M	-$6.75M	-17.4%	Mar 31, 2020	10-Q	2020-05-12
Q4 2019	$38.2M	-$4.98M	-11.5%	Dec 31, 2019	10-K	2021-03-03
Q3 2019	$28.7M	-$2.11M	-6.84%	Sep 30, 2019	10-Q	2019-11-13
Q2 2019	$34.1M	+$790K	+2.37%	Jun 30, 2019	10-Q	2019-08-07
Q1 2019	$38.9M	+$2.54M	+6.98%	Mar 31, 2019	10-Q	2019-05-13
Q4 2018	$43.2M	+$4.13M	+10.6%	Dec 31, 2018	10-K	2020-03-04
Q3 2018	$30.8M	+$4.45M	+16.9%	Sep 30, 2018	10-Q	2018-11-14
Q2 2018	$33.3M	+$2.96M	+9.75%	Jun 30, 2018	10-Q	2018-08-14
Q1 2018	$36.3M	+$2.47M	+7.28%	Mar 31, 2018	10-Q	2018-05-15
Q4 2017	$39M	+$33.5M	+601%	Dec 31, 2017	10-K	2019-03-20
Q3 2017	$26.4M	+$18.1M	+218%	Sep 30, 2017	10-Q	2017-11-14
Q2 2017	$30.4M	+$24.8M	+449%	Jun 30, 2017	10-Q	2017-08-11
Q1 2017	$33.9M	+$24.5M	+261%	Mar 31, 2017	10-Q	2017-05-11
Q4 2016	$5.56M	-$2.64M	-32.1%	Dec 31, 2016	10-K	2018-04-02
Q3 2016	$8.31M	+$1.02M	+14%	Sep 30, 2016	10-Q	2016-11-14
Q2 2016	$5.54M	-$3.24M	-36.9%	Jun 30, 2016	10-Q	2016-08-12
Q1 2016	$9.39M	-$677K	-6.73%	Mar 31, 2016	10-Q/A	2016-08-09
Q4 2015	$8.2M	-$195K	-2.32%	Dec 31, 2015	10-K	2017-03-15
Q3 2015	$7.29M	+$5.59M	+330%	Sep 30, 2015	10-Q	2015-11-12
Q2 2015	$8.77M			Jun 30, 2015	10-Q	2015-08-10
Q1 2015	$10.1M			Mar 31, 2015	10-Q	2015-05-04
Q4 2014	$8.4M	+$6.81M	+429%	Dec 31, 2014	10-K	2016-03-25
Q3 2014	$1.7M			Sep 30, 2014	10-Q	2014-12-18
Q4 2013	$1.59M			Dec 31, 2013	10-K	2015-03-13

Previous1Next

Showing 1 to 43 of 43 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.